Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹590 Cr₹611 Cr₹1,695 Cr₹358 Cr₹93 Cr

What is the latest Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹590 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹590 Cr
Mar2024₹611 Cr
Mar2023₹1,695 Cr
Mar2022₹358 Cr
Mar2021₹93 Cr

How is Consolidated Net Profit of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹590 Cr
-3.39
Mar2024 ₹611 Cr
-63.97
Mar2023 ₹1,695 Cr
373.19
Mar2022 ₹358 Cr
284.26
Mar2021 ₹93 Cr -

Compare Consolidated Net Profit of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹54,206.3 Cr -2.2% -3.4% 28.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 0.6% -0.4% 4.7% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.2% 1.7% 47.3% Stock Analytics
CIPLA ₹120,428.0 Cr -0.2% -1.4% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.8% 12.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -2.6% -8.1% -4.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.2%

-3.4%

28.9%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses